1.
Jianpi Yiqi Busui prescription alleviates myasthenia gravis by regulating Th17 through the TAK1/P38 MAPK/eIF-4E signaling pathway. Biomol Biomed [Internet]. 2025 Aug. 5 [cited 2025 Aug. 18];25(9):2004–2019. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/11546